| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.31 | 2e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.29 | 4e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 7e-07 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |